Ignyte Acquisition Corp.

Ignyte Acquisition Corp.

IGNYW
Ignyte Acquisition Corp.US flagNASDAQ Capital Market
0.17
USD
-0.14
- -
Ignyte Acquisition Corp.
IGNYW
(NASDAQ Capital Market)

Recent

price

0.17

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Ignyte Acquisition Corp. functioned as a special purpose acquisition company, established to complete a significant merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or another similar business combination with one or more businesses or entities. Formed in 2020 and based in New York, New York, the entity successfully consummated its business combination with Peak Bio, Inc. on November 1, 2022. Following this transaction, the combined enterprise now operates under the name Peak Bio, Inc., focusing on its biopharmaceutical initiatives, with its common stock and warrants trading under new symbols.